Do patient anxiety levels decrease urodynamic test reproducibility?
Research type
Research Study
Full title
Does increased levels of anxiety decrease the reproducibility of symptoms during urodynamic studies in women?
IRAS ID
172112
Contact name
Victor Olagundoye
Contact email
Sponsor organisation
SWBH
Duration of Study in the UK
0 years, 10 months, 18 days
Research summary
This study will look at how pre-test anxiety levels affect the reproducibility of symptoms during routine urodynamic testing in women. Urodynamics is a test that assesses the function of the lower urinary tract, including the bladder.
The results of urodynamic tests often determine treatment for patients, which may include bladder retraining, medication and/or surgery. Thus, it is important for the results of urodynamics to be accurate and representative of the patient’s symptoms outside of the clinic.
Females over 18 years of age who can consent for themselves will be included in the study. Only patients who are undergoing urodynamics for the first time will be included in the study. Potential participants will be recruited through Sandwell and West Birmingham Hospitals NHS Trust Urogynaecology clinics and informed consent obtained prior to inclusion in the study.
Patients will be recruited until a total of 30 results have been obtained. This study is being put forward as a pilot study.
Pre-test anxiety levels in women undergoing urodynamics will be measured using a validated questionnaire HADS. (Hospital anxiety and depression scale). The patient, prior to their routine urodynamics test, will fill out this self-administered questionnaire.
Reproducibility of patient symptoms will be measured using a non-validated quantitative bladder test assessment. The patient will fill out this self-administered quantitative bladder assessment after their urodynamics test.
Filling out both of these sets of questions will take approximately 10 minutes of the patient’s time. This is the extent of patient participation required for this study.
The pre-test anxiety and symptom reproducibility variables will be correlated against each other to assess whether there is correlation between the two. A Spearman Rho test will be used to assess the strength of the relationship between these.
REC name
HSC REC B
REC reference
15/NI/0084
Date of REC Opinion
15 Jul 2015
REC opinion
Further Information Favourable Opinion